Test dello spettro anticorpale di Covid lungo (AMVAIS)

The Attomarker Multi-Variant Antibody Immunity Spectrum (AMVAIS) test helps us to get one step closer to precision medicine in Long Covid treatments – in this case especially in the area of antiviral therapy. Antibodies are a vital part of our immune systems. When analysing patient antibody responses across a range of COVID variants, it is evident that individual immunity and hence how vulnerable a person is, noticeably varies. In case of the AMVAIS test these individual responses are called immunity endotypes. 

Prevediamo di restituire i risultati entro 2 settimane dal ricevimento del campione. Riceverete: uno spettro anticorpale e un rapporto di laboratorio.

Prof Andrew Shaw sul profilo immunitario degli anticorpi a Long Covid (fonte video: LCCWYCD)

 *Service  provided by Attomarker